Greenwich LifeSciences, Inc. (GLSI) › Shareholders' EquityGreenwich LifeSciences, Inc. (GLSI) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2018: -$10.12M2019: -$1.35M2020: $27.63M2021: $26.83M2022: $13.21M2023: $6.70M2024: $908.6K2025: $353.2K$353.2K2018Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$353.2K-61.1%2024$908.6K-86.4%2023$6.70M-49.3%2022$13.21M-50.8%2021$26.83M-2.9%2020$27.63M+2146.1%2019-$1.35M+86.7%2018-$10.12M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share